ACER THERAPEUTICS INC's ticker is ACER and the CUSIP is 00444P108. A total of 28 filers reported holding ACER THERAPEUTICS INC in Q3 2020. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2023 | $81,309 | +21.8% | 88,054 | +0.1% | 0.00% | – |
Q1 2023 | $66,737 | -69.8% | 87,985 | -0.0% | 0.00% | – |
Q4 2022 | $220,875 | +81.0% | 87,998 | 0.0% | 0.00% | – |
Q3 2022 | $122,000 | +3.4% | 87,998 | -5.8% | 0.00% | – |
Q2 2022 | $118,000 | -57.2% | 93,381 | -1.9% | 0.00% | – |
Q1 2022 | $276,000 | +27.2% | 95,233 | -0.1% | 0.00% | – |
Q4 2021 | $217,000 | -11.1% | 95,343 | +0.0% | 0.00% | – |
Q3 2021 | $244,000 | -10.6% | 95,342 | 0.0% | 0.00% | – |
Q2 2021 | $273,000 | -8.1% | 95,342 | 0.0% | 0.00% | – |
Q1 2021 | $297,000 | +18.8% | 95,342 | 0.0% | 0.00% | – |
Q4 2020 | $250,000 | +127.3% | 95,342 | +149.4% | 0.00% | – |
Q3 2020 | $110,000 | -20.3% | 38,223 | -5.2% | 0.00% | – |
Q2 2020 | $138,000 | +43.8% | 40,312 | -16.1% | 0.00% | – |
Q1 2020 | $96,000 | -52.9% | 48,073 | -5.7% | 0.00% | – |
Q4 2019 | $204,000 | -37.4% | 50,982 | -50.1% | 0.00% | – |
Q3 2019 | $326,000 | -7.4% | 102,244 | +13.3% | 0.00% | – |
Q2 2019 | $352,000 | -68.3% | 90,204 | +97.4% | 0.00% | – |
Q1 2019 | $1,110,000 | +187.6% | 45,686 | +137.9% | 0.00% | – |
Q4 2018 | $386,000 | – | 19,204 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Worth Venture Partners, LLC | 250,518 | $722,000 | 0.59% |
Nantahala Capital Management | 990,655 | $2,853,000 | 0.09% |
GSA CAPITAL PARTNERS LLP | 82,421 | $237,000 | 0.04% |
FEDERATED HERMES, INC. | 117,673 | $339,000 | 0.00% |
BNP PARIBAS FINANCIAL MARKETS | 179 | $516,000 | 0.00% |
Horan Securities, Inc. | 24 | $0 | 0.00% |
OSAIC HOLDINGS, INC. | 200 | $1,000 | 0.00% |
BANK OF AMERICA CORP /DE/ | 3 | $0 | 0.00% |
WELLS FARGO & COMPANY/MN | 29 | $0 | 0.00% |
NORTHERN TRUST CORP | 31,083 | $90,000 | 0.00% |